查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828126

2025年全球HPV和PAP检测市场报告

HPV Testing And Pap Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，HPV和PAP检测市场规模强劲成长，从2024年的44亿美元增加到2025年的48.3亿美元，复合年增长率为9.8%。预测期内的成长可归因于子宫颈癌宣传宣传活动、筛检计画的实施、政府措施和资金投入、女性健康倡议、疾病负担的增加以及妇科筛检应用的增加。

HPV 和 PAP 检测市场规模预计将在未来几年快速成长，到 2029 年将达到 76.4 亿美元，复合年增长率为 12.1%。预测期内的成长可归因于疫苗接种计划、精准医疗方法、分子诊断的整合、全球健康股权倡议、人口老化以及诊断检测报销政策。预测期内的主要趋势包括向 HPV 检测的转变、协作检测方法、分子检测的普及、检测流程的自动化以及居家检测选项。

HPV 和 PAP 测试是用于识别女性子宫颈癌的筛检测试，旨在发现可能导致癌症的异常变化的早期征兆。

HPV 和 PAP 检测的主要类型毫无疑问是 HPV 和 PAP 检测，它们使医疗保健提供者能够确定患者体内是否存在人类乳突病毒 (HPV)。与这些检测相关的主要产品包括设备、耗材以及利用聚合酵素链锁反应( PCR)、免疫诊断和其他相关技术的服务。这些筛检方法通常用于子宫颈癌和阴道癌筛检，并被医院、诊所、实验室和其他各种终端使用者广泛采用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列涵盖 HPV 和 PAP 检测市场统计数据，并提供全球市场规模、区域份额、HPV 和 PAP 检测市场份额竞争对手、详细的 HPV 和 PAP 检测细分市场、市场趋势和机会，以及在 HPV 和 PAP 检测行业取得成功所需的其他数据。本 HPV 和 PAP 检测市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的所有完整观点。

未来五年的预测成长率为12.1%，较我们先前对该市场的预测略有下降0.1%。下降的主要原因是美国与其他国家之间的关税影响。这可能会透过对来自荷兰和新加坡等主要地区的液基细胞学管瓶和DNA杂合反应探针征收关税直接影响美国，从而导致子宫颈癌筛检能力下降和诊断检测成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

HPV 和 PAP 检测市场正随着子宫颈癌盛行率的上升而蓬勃发展。子宫颈癌的特征是子宫颈细胞不受控制地生长，凸显了透过 HPV 和 PAP 检测等方法进行早期发现的重要性。 2023 年 1 月，美国癌症协会报告称，美国新增子宫颈癌病例约 13,960 例，死亡病例约 4,310 例。子宫颈癌患者数量的快速成长是推动 HPV 和 PAP 检测市场发展的关键因素。

HPV和PAP检测市场的预期成长也受到老年人口成长的推动。随着人口老化，预防性医疗保健变得越来越重要，需要定期筛检，例如HPV检测和PAP抹片检查，以便及早发现子宫颈异常。世界卫生组织（WHO）于2022年10月预测，到2030年，全球六分之一的人将年满60岁或以上，到2050年，这一年龄层的人口将达到21亿。老年人口的成长正在促进HPV和PAP检测市场的扩张。

HPV 和 PAP 检测市场的一个关键趋势是，领先公司为了维持市场地位而不断推出产品创新。 2022 年 1 月，总部位于加纳的生物技术公司 Yemaachi BIoTechnology 推出了 Sheba HPV 检测试剂盒，这是一款高效的家用采样试剂套件，利用聚合酵素链锁反应(PCR) 技术检测人类乳突病毒。这项创新解决方案可识别子宫颈癌高风险女性。

为了涵盖更广泛的客户群、推动销售并增加收益，HPV 和 PAP 检测市场的主要企业也在专注于开发自我采样解决方案。自我采样是指个人独立采集样本，无需外部专家的直接参与。 2022 年 6 月，瑞士製药公司 F. Hoffmann-La Roche AG 推出了 HPV 自我采样解决方案，使患者能够在医疗机构内，在医疗保健专业人员的指导下，私下采集阴道样本进行 HPV筛检。自我采集的检体使用罗氏的 cobas HPV 检测进行分析，该检测已证明其检测性能与传统临床医生采集的检体相当。

2022年11月，美国医疗检测公司Quest Diagnostics收购了SummaHealth的推广检测服务业务。此次收购扩大了Quest诊断创新的覆盖范围，并改善了俄亥俄州东北部社区的健康。 SummaHealth提供HPV和PAP检测，为医生和患者提供Quest先进的检测服务、广泛的患者服务点、全面的医疗保险覆盖以及降低各项服务的自付费用，最终有助于改善该地区的医疗保健状况。

HPV 和 PAP 检测市场的主要企业包括雅培实验室 (Abbott Laboratories)、Qiagen NV、Becton Dickinson and Company、Quest Diagnostics Inc.、Hologic Inc.、F. Hoffmann-La Roche AG、Femasys Inc.、Arbor Vita Corporation、Seegene Inc.、赛默飞世科技 (TheTmok, Fisher Scir. Inc.、TruScreen Group Limited、丹纳赫集团 (Danaher Corporation)、Mylab Discovery Solutions Pvt. Ltd.、Fujirebio Diagnostics Inc.、Promega Corporation、Myriad Genetics Inc.、DiaSorin SpA、Genomica SAU、Grifols SA、Illumina Inc.、DiaSorin SpA、Genomica SAU、Grifols SA、Illumina Inc.、 Ltd.)、西门子医疗集团 (Siemens Healthineers AG)、Trovagene Inc.、Vela Diagnostics、Zymo Research Corp. 和 CerviCusco。

2024年，北美是HPV和PAP检测市场最大的地区。预计亚太地区将成为预测期内全球HPV和PAP检测市场成长最快的地区。 HPV和PAP检测市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

HPV 和 PAP 检测市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

HPV 和 PAP 检测市场由营业单位从传统 PAP 检测、液基 PAP 检测、HPV DNA 检测和联合检测中获得的收益组成。市场规模包括服务提供者销售的或包含在其服务产品中的相关产品的价值。 HPV 和 PAP 检测市场也包括 HPV 和 PAP检测套组的销售。此市场价值为“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 HPV 和 PAP 检测：PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球 HPV 与 PAP 检测市场：成长率分析
  • 全球 HPV 与 PAP 检测市场表现：规模与成长，2019-2024 年
  • 全球 HPV 与 PAP 检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球 HPV 和 PAP 检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球HPV和PAP检测市场（按检测类型、性能和预测），2019-2024年，2024-2029年，2034年
  • HPV检测
  • 巴氏抹片检查
  • 全球HPV和PAP检测市场（按产品、性能和预测），2019-2024年，2024-2029年，2034年
  • 装置
  • 耗材
  • 服务
  • 全球HPV和PAP检测市场（按技术、性能和预测），2019-2024年，2024-2029年，2034年
  • 聚合酵素链锁反应（PCR）
  • 免疫诊断
  • 其他的
  • 全球HPV和PAP检测市场的应用、效能和预测（2019-2024年、2024-2029年、2034年）
  • 子宫颈癌筛检
  • 阴道癌筛检
  • 全球HPV及PAP检测市场（依最终用户、绩效及预测），2019-2024年、2024-2029年、2034年
  • 医院和诊所
  • 实验室
  • 其他的
  • 全球 HPV 和 PAP 检测市场：HPV 检测细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 高危险HPV检测
  • 低风险HPV检测
  • HPV基因分型
  • 全球 HPV 和 PAP 检测市场：PAP 检测细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 常规巴氏抹片检查
  • 液态巴氏抹片检查
  • PAP 加 HPV 检测

第七章 区域和国家分析

  • 全球 HPV 和 PAP 检测市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球 HPV 与 PAP 检测市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • HPV 与 PAP 侦测市场：竞争格局
  • HPV 与 PAP 检测市场：公司简介
    • Abbott Laboratories
    • Qiagen NV
    • Becton Dickinson and Company
    • Quest Diagnostics Inc.
    • Hologic Inc.

第31章：其他领先和创新企业

  • F. Hoffmann-La Roche AG
  • Femasys Inc.
  • Arbor Vita Corporation
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • BioMerieux SA
  • Onco Health Corporation
  • Takara Bio Inc.
  • TruScreen Group Limited
  • Danaher Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Fujirebio Diagnostics Inc.
  • Promega Corporation
  • Myriad Genetics Inc.
  • DiaSorin SpA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年 HPV 与 PAP 检测市场：提供新机会的国家
  • 2029 年 HPV 与 PAP 检测市场：细分领域带来新机会
  • 2029 年 HPV 与 PAP 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24208u

HPV testing and Pap tests are screening procedures utilized to identify cervical cancer in women, aiming to detect early signs of abnormal changes that could potentially lead to cancer.

The primary types of HPV testing and Pap tests include, unsurprisingly, HPV testing and Pap tests. HPV testing involves healthcare providers checking for the presence of the human papillomavirus (HPV) in a patient's body. The main products associated with these tests include instruments, consumables, and services utilizing technologies such as polymerase chain reaction (PCR), immunodiagnostics, and other relevant technologies. These screening methods find application in cervical cancer screening and vaginal cancer screening and are commonly employed by hospitals, clinics, laboratories, and various other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The HPV testing and Pap tests market research report is one of a series of new reports from The Business Research Company that provides HPV testing and Pap tests market statistics, including global market size, regional shares, competitors with a HPV testing and Pap tests market share, detailed HPV testing and Pap tests market segments, market trends and opportunities, and any further data you may need to thrive in the HPV testing and Pap tests industry. This HPV testing and Pap tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hpv testing and pap test market size has grown strongly in recent years. It will grow from $4.4 billion in 2024 to $4.83 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to cervical cancer awareness campaigns, screening program implementations, government initiatives and funding, women's health advocacy, increased disease burden, gynecological examination practices.

The hpv testing and pap test market size is expected to see rapid growth in the next few years. It will grow to $7.64 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to vaccination programs, precision medicine approaches, integration of molecular diagnostics, global health equity initiatives, aging population dynamics, and diagnostic test reimbursement policies. Major trends in the forecast period include a shift towards HPV testing, co-testing approaches, the adoption of molecular testing, automation in testing processes, and home-based testing options.

The forecast of 12.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on liquid-based cytology vials and DNA hybridization probes, sourced from key regions such as the Netherlands and Singapore, which could lead to reduced cervical cancer screening capacity and higher diagnostic laboratory expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The HPV testing and Pap test markets are experiencing growth driven by an increase in the prevalence of cervical cancer. Cervical cancer, characterized by uncontrolled cell growth in the cervix, underscores the importance of early detection through methods such as HPV testing and Pap tests. In January 2023, the American Cancer Society reported an estimated 13,960 new cases of cervical cancer in the US, with approximately 4,310 expected deaths. This surge in cervical cancer cases is a significant factor propelling the HPV testing and Pap test market forward.

Anticipated growth in the HPV testing and Pap test market is also attributed to the rising geriatric population. As individuals age, preventive healthcare becomes a focal point, prompting regular screenings such as HPV testing and Pap smears for the early detection of cervical abnormalities. In October 2022, the World Health Organization (WHO) projected that one in six people globally would be 60 or older by 2030, with 2.1 billion individuals expected to fall into this age group by 2050. The increasing geriatric population is thus contributing to the expansion of the HPV testing and Pap test market.

A key trend in the HPV testing and Pap test markets is the introduction of product innovations by major companies aiming to sustain their market positions. In January 2022, Ghana-based biotechnology company Yemaachi Biotechnology launched the Sheba HPV Test, an efficient home sampling kit utilizing polymerase chain reaction (PCR) technology for the detection of human papillomavirus. This innovative solution identifies women at high risk of cervical cancer.

Major companies in the HPV testing and Pap test market are also focusing on developing self-sampling solutions to cater to a broader customer base, increase sales, and boost revenue. Self-sampling involves individuals collecting samples independently, without the direct involvement of external professionals. In June 2022, Swiss pharmaceutical company F. Hoffmann-La Roche AG introduced an HPV self-sampling solution, allowing patients to privately collect vaginal samples for HPV screening within healthcare facilities under healthcare worker guidance. The self-collected samples undergo analysis using the Roche Cobas HPV test, demonstrating test performance comparable to samples collected traditionally by clinicians.

In November 2022, Quest Diagnostics, a US-based medical laboratories company, acquired the outreach laboratory services business of Summa Health. This acquisition extends Quest's diagnostic innovation reach and enhances health outcomes in Northeastern Ohio communities. Summa Health, a provider of HPV and Pap tests, offers physicians and patients access to Quest's advanced test menu, extensive patient access sites, comprehensive health plan coverage, and reduced out-of-pocket costs for various services, ultimately contributing to improved healthcare in the region.

Major companies operating in the HPV testing and pap test market include Abbott Laboratories, Qiagen N.V., Becton Dickinson and Company, Quest Diagnostics Inc., Hologic Inc., F. Hoffmann-La Roche AG, Femasys Inc., Arbor Vita Corporation, Seegene Inc., Thermo Fisher Scientific Inc., BioMerieux SA, Onco Health Corporation, Takara Bio Inc., TruScreen Group Limited, Danaher Corporation, Mylab Discovery Solutions Pvt. Ltd., Fujirebio Diagnostics Inc., Promega Corporation, Myriad Genetics Inc., DiaSorin S.p.A., Genomica S.A.U., Grifols S.A., Illumina Inc., Merck & Co. Inc., Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers AG, Trovagene Inc., Vela Diagnostics, Zymo Research Corp., CerviCusco

North America was the largest region in the HPV testing and Pap test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global HPV testing and Pap tests market report during the forecast period. The regions covered in the hpv testing and pap test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hpv testing and pap test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The HPV testing and Pap test market consist of revenues earned by entities by conventional Pap test, liquid-based Pap test, HPV DNA test and co-testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The HPV testing and Pap test market also consist of sales of HPV testing and Pap test kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HPV Testing And Pap Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hpv testing and pap test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hpv testing and pap test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hpv testing and pap test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: HPV Testing; Pap Test
  • 2) By Product: Instruments; Consumables; Services
  • 3) By Technology: Polymerase Chain Reaction (PCR); Immunodiagnostics; Other Technologies
  • 4) By Application: Cervical Cancer Screening; Vaginal Cancer Screening
  • 5) By End User: Hospitals And Clinics; Laboratories; Other End Users
  • Subsegments:
  • 1) By HPV Testing: High-Risk HPV Testing; Low-Risk HPV Testing; HPV Genotyping
  • 2) By Pap Test: Conventional Pap Test; Liquid-Based Pap Test; Pap Plus HPV Testing
  • Companies Mentioned: Abbott Laboratories; Qiagen N.V.; Becton Dickinson and Company; Quest Diagnostics Inc.; Hologic Inc.; F. Hoffmann-La Roche AG; Femasys Inc.; Arbor Vita Corporation; Seegene Inc.; Thermo Fisher Scientific Inc.; BioMerieux SA; Onco Health Corporation; Takara Bio Inc.; TruScreen Group Limited; Danaher Corporation; Mylab Discovery Solutions Pvt. Ltd.; Fujirebio Diagnostics Inc.; Promega Corporation; Myriad Genetics Inc.; DiaSorin S.p.A.; Genomica S.A.U.; Grifols S.A.; Illumina Inc.; Merck & Co. Inc.; Quidel Corporation; Randox Laboratories Ltd.; Siemens Healthineers AG; Trovagene Inc.; Vela Diagnostics; Zymo Research Corp.; CerviCusco
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. HPV Testing And Pap Test Market Characteristics

3. HPV Testing And Pap Test Market Trends And Strategies

4. HPV Testing And Pap Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global HPV Testing And Pap Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global HPV Testing And Pap Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global HPV Testing And Pap Test Market Growth Rate Analysis
  • 5.4. Global HPV Testing And Pap Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global HPV Testing And Pap Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global HPV Testing And Pap Test Total Addressable Market (TAM)

6. HPV Testing And Pap Test Market Segmentation

  • 6.1. Global HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HPV Testing
  • Pap Test
  • 6.2. Global HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Services
  • 6.3. Global HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Immunodiagnostics
  • Other Technologies
  • 6.4. Global HPV Testing And Pap Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • 6.5. Global HPV Testing And Pap Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Laboratories
  • Other End Users
  • 6.6. Global HPV Testing And Pap Test Market, Sub-Segmentation Of HPV Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Risk HPV Testing
  • Low-Risk HPV Testing
  • HPV Genotyping
  • 6.7. Global HPV Testing And Pap Test Market, Sub-Segmentation Of Pap Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Pap Test
  • Liquid-Based Pap Test
  • Pap Plus HPV Testing

7. HPV Testing And Pap Test Market Regional And Country Analysis

  • 7.1. Global HPV Testing And Pap Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global HPV Testing And Pap Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific HPV Testing And Pap Test Market

  • 8.1. Asia-Pacific HPV Testing And Pap Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China HPV Testing And Pap Test Market

  • 9.1. China HPV Testing And Pap Test Market Overview
  • 9.2. China HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India HPV Testing And Pap Test Market

  • 10.1. India HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan HPV Testing And Pap Test Market

  • 11.1. Japan HPV Testing And Pap Test Market Overview
  • 11.2. Japan HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia HPV Testing And Pap Test Market

  • 12.1. Australia HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia HPV Testing And Pap Test Market

  • 13.1. Indonesia HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea HPV Testing And Pap Test Market

  • 14.1. South Korea HPV Testing And Pap Test Market Overview
  • 14.2. South Korea HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe HPV Testing And Pap Test Market

  • 15.1. Western Europe HPV Testing And Pap Test Market Overview
  • 15.2. Western Europe HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK HPV Testing And Pap Test Market

  • 16.1. UK HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany HPV Testing And Pap Test Market

  • 17.1. Germany HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France HPV Testing And Pap Test Market

  • 18.1. France HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy HPV Testing And Pap Test Market

  • 19.1. Italy HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain HPV Testing And Pap Test Market

  • 20.1. Spain HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe HPV Testing And Pap Test Market

  • 21.1. Eastern Europe HPV Testing And Pap Test Market Overview
  • 21.2. Eastern Europe HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia HPV Testing And Pap Test Market

  • 22.1. Russia HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America HPV Testing And Pap Test Market

  • 23.1. North America HPV Testing And Pap Test Market Overview
  • 23.2. North America HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA HPV Testing And Pap Test Market

  • 24.1. USA HPV Testing And Pap Test Market Overview
  • 24.2. USA HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada HPV Testing And Pap Test Market

  • 25.1. Canada HPV Testing And Pap Test Market Overview
  • 25.2. Canada HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America HPV Testing And Pap Test Market

  • 26.1. South America HPV Testing And Pap Test Market Overview
  • 26.2. South America HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil HPV Testing And Pap Test Market

  • 27.1. Brazil HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East HPV Testing And Pap Test Market

  • 28.1. Middle East HPV Testing And Pap Test Market Overview
  • 28.2. Middle East HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa HPV Testing And Pap Test Market

  • 29.1. Africa HPV Testing And Pap Test Market Overview
  • 29.2. Africa HPV Testing And Pap Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa HPV Testing And Pap Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa HPV Testing And Pap Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. HPV Testing And Pap Test Market Competitive Landscape And Company Profiles

  • 30.1. HPV Testing And Pap Test Market Competitive Landscape
  • 30.2. HPV Testing And Pap Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. HPV Testing And Pap Test Market Other Major And Innovative Companies

  • 31.1. F. Hoffmann-La Roche AG
  • 31.2. Femasys Inc.
  • 31.3. Arbor Vita Corporation
  • 31.4. Seegene Inc.
  • 31.5. Thermo Fisher Scientific Inc.
  • 31.6. BioMerieux SA
  • 31.7. Onco Health Corporation
  • 31.8. Takara Bio Inc.
  • 31.9. TruScreen Group Limited
  • 31.10. Danaher Corporation
  • 31.11. Mylab Discovery Solutions Pvt. Ltd.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Promega Corporation
  • 31.14. Myriad Genetics Inc.
  • 31.15. DiaSorin S.p.A.

32. Global HPV Testing And Pap Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The HPV Testing And Pap Test Market

34. Recent Developments In The HPV Testing And Pap Test Market

35. HPV Testing And Pap Test Market High Potential Countries, Segments and Strategies

  • 35.1 HPV Testing And Pap Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 HPV Testing And Pap Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 HPV Testing And Pap Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer